University of Queensland-led research shows being overweight can impair the body’s antibody response to SARS-CoV-2 infection but not to the protection offered by vaccination.
LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union – Biotech Investments
EQS-News: Lindis Biotech GmbH / Key word(s): Regulatory Admission LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union 21.10.2024 / 09:00